Phenotypic and genotypic characterization of plasmid-mediated AmpC β-lactamases in Klebsiella pneumoniae isolates from Mansoura University Children Hospital | ||||
Egyptian Journal of Medical Microbiology | ||||
Volume 28, Issue 3, July 2019, Page 105-110 PDF (408.22 K) | ||||
Document Type: New and original researches in the field of Microbiology. | ||||
DOI: 10.21608/ejmm.2019.283061 | ||||
View on SCiNiTO | ||||
Authors | ||||
Safaa M. EL-Ageery1; Noha T. Abou El-Khier 1; Mayada S. Zeid2 | ||||
1Medical Microbiology and Immunology Department, Faculty of Medicine, Mansoura University, Egypt | ||||
2Infectious Diseases and Malnutrition Unit, Children Hospital, Faculty of Medicine, Mansoura University, Egypt | ||||
Abstract | ||||
Background: The plasmid mediated AmpC β-lactamases (pAmpCs) production is one of the most essential mechanism of drug resistance in Klebsiella pneumoniae (K. pneumoniae). Objective: Phenotypic and genotypic investigation of plasmid mediated AmpC β -lactamase production in K. pneumoniae and its antimicrobial profile among pediatric patients. Methodology: Ninety-two K. pneumoniae isolates were tested for pAmpC β-lactamase production by cefoxitin disk diffusion test. Multiplex polymerase chain reaction (multiplex PCR) was done to detect plasmid mediated AmpC β-lactamases genes in the cefoxitin resistant isolates. Antimicrobial susceptibility testing was done to pAmpC β- lactamase positive isolates by means of Kirby Bauer disc diffusion method. Results: Out of the 92 K. pneumoniae isolates, 37 strains (40.21%) were resistant to cefoxitin. Plasmid mediated AmpC genes were detected in 67.56% (25/37), ten isolates (40%) had CMY gene, 8 isolates (32%) had DHA gene and 7 isolates (28%) had FOX gene. All of the 25(100%) isolates were resistant to co-amoxiclav, ceftazidime, cefotaxime, cefuroxime, ceftriaxone and cefoxitin and 7 isolates (28%) showed resistance against imipenem with variable susceptibilities to the other antibiotics. Conclusion: Monitoring of Plasmid mediated AmpC β-lactamase producing K. pneumoniae is important because of its high prevalence among pediatric patients. Imipenem was the drug of choice for treatment of such infections. | ||||
Keywords | ||||
K. pneumoniae; AmpC β-lactamase; plasmid; pediatric patients | ||||
Statistics Article View: 54 PDF Download: 35 |
||||